FIELD: medicine.
SUBSTANCE: group of inventions refers to a storage-stable composition containing PTHrP (Parathyriod Hormone-Related Protein), and to a method for using a PTHrP analogue and PTHrP compositions declared in accordance with the present invention for bone mass gain and bone tissue improvement.
EFFECT: composition is storage-stable, and can be generally stored at room temperature for at least several weeks that facilitates the easy parenteral infusion into the patients.
28 cl, 2 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENTS FOR REDUCTION OF PARATHYROID HORMONE LEVELS | 2010 |
|
RU2557654C2 |
| COMPOSITIONS AND METHODS FOR USING PEPTIDES OF NEEGENIOSIS ISLANDS AND ANALOGUES THEREOF | 2014 |
|
RU2685958C2 |
| POLYPEPTIDES SELECTIVE TO GLUCAGON RECEPTORS AND THEIR APPLICATION METHODS | 2017 |
|
RU2760007C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF | 2019 |
|
RU2778572C1 |
| PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2605288C2 |
| COMPOSITIONS OF ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2772781C2 |
| STABLE COMPOSITIONS WITH HIGH CONCENTRATIONS OF PROTEINS OF HUMAN ANTIBODIES AGAINST TNF-ALPHA | 2010 |
|
RU2560701C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION | 2018 |
|
RU2766590C2 |
| HIGHLY CONCENTRATED COMPOSITIONS OF ANTIBODIES TO C5 | 2018 |
|
RU2787595C2 |
| NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
